Identification of CD4+CD25+CD127- regulatory t cells and CD14+HLA-DR-/low myeloid-derived suppressor cells and their roles in the prognosis of breast cancer

Biomedical Reports

Volumn 5, Issue 2, 2016, Pages 208-212

  Wang, Jinhu ^a   Yang, Jianhong ^a  

^a Soochow Medical College of Soochow University   (China)

Author keywords

Breast cancer; Myeloid derived suppressor cells; Prognosis; T regulatory cells

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 2; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BREAST CANCER; CELL ISOLATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MIDDLE AGED; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; UPREGULATION;

EID: 84998633295     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2016.694     Document Type: Article

References (26)

1. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC and George WD; Scottish Cancer Trials Breast Group: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348: 708-713, 1996.
2. Stewart BW and Kleihues P (eds): World cancer report. In: International Agency for Research on Cancer. IARC Press, Lyon, 2003.
3. Mehta P: Potential role of platelets in the pathogenesis of tumor metastasis. Blood 63: 55-63, 1984.
4. Gilboa E: The risk of autoimmunity associated with tumor immunotherapy. Nat Immunol 2: 789-792, 2001.
5. Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H and Fujii H: Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer 98: 148-153, 2008.
6. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG and Levings MK: Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19: 345-354, 2007.
7. Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, Hodek J, Ovesna J and Michalek J: ΜicroRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol 260: 70-74, 2010.
8. Nagaraj S and Gabrilovich DI: Myeloid-derived suppressor cells. Adv Exp Med Biol 601: 213-223, 2007.
9. Srivastava MK, Bosch JJ, Thompson JA, Ksander BR, Edelman MJ and Ostrand-Rosenberg S: Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells. Cancer Immunol Immunother 57: 1493-1504, 2008.
10. Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ and Montero AJ: Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 58: 49-59, 2009.
11. Poschke I, Mougiakakos D, Hansson J, Masucci GV and Kiessling R: Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res 70: 4335-4345, 2010.
12. Adegboyega TO, Landercasper J, Linebarger JH, et al: Institutional review of compliance with NCCN guidelines for breast cancer: Lessons learned from real-time multidimensional synoptic reporting. J Natl Compr Canc Netw 13: 177-183, 2015.
13. Ulmer AJ, Scholz W, Ernst M, Brandt E and Flad HD: Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology 166: 238-250, 1984.
14. Lyons AB and Parish CR: Determination of lymphocyte division by flow cytometry. J Immunol Methods 171: 131-137, 1994.
15. Nagaraj S and Gabrilovich DI: Myeloid-derived suppressor cells in human cancer. Cancer J 16: 348-353, 2010.
16. Filipazzi P, Huber V and Rivoltini L: Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother 61: 255-263, 2012.
17. Wang L, Chang EWY, Wong SC, Ong S-M, Chong DQ and Ling KL: Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 190: 794-804, 2013.
18. Mohapatra SS, Bharadwaj SN and Mohapatra S: Compositions and methods for modulating myeloid derived suppressor cells. US Patent 20140336239 A1. Filed December 3, 2011; issued November 13, 2014.
19. Lindau D, Gielen P, Kroesen M, Wesseling P and Adema GJ: The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 138: 105-115, 2013.
20. Gros A, Turcotte S, Wunderlich JR, Ahmadzadeh M, Dudley ME and Rosenberg SA: Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. Clin Cancer Res 18: 5212-5223, 2012.
21. Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, Woo T and Epstein AL: Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J Transl Med 9: 90, 2011.
22. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352, 2005.
23. Ramsdell F: Foxp3 and natural regulatory T cells: Key to a cell lineage? Immunity 19: 165-168, 2003.
24. Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding J, Zhu J, Wei H and Zhao K: Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS One 8: e57114, 2013.
25. Hein F, Massin F, Cravoisy-Popovic A, Barraud D, Levy B, Bollaert PE and Gibot S: The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states. Crit Care 14: R19, 2010.
26. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas St Groth B, et al: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711, 2006.